跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BIVALIRUDIN INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
BIVALIRUDIN INJECTION
Authorized
STANDARD
BIVALIRUDIN INJECTION
avir pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
123921b62a347c2b
Company
avir pharma inc.
Type
Standard
Approval Details
Approval Id
123921b62a347c2b
Drug Approval Canada Name
BIVALIRUDIN INJECTION
Product Name
BIVALIRUDIN INJECTION
Status
Marketed
Status Date
2021-03-05
Original Market Date
2021-03-05
Din
02505517
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:12.04.12
Atc Original
B01AE06 BIVALIRUDIN
Atc Name
b 01 ae 06
Aig Number
0148342002
Company Name
avir pharma inc.
Company Address
660 Boulevard Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
BIVALIRUDIN
5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
123921b62a347c2b
Type
Standard
Back to Health Canada Approvals